Novelion Therapeutics Inc. (NVLN) Fell -5.41% or -0.22 To Price $3.85 On Tuesday


Novelion Therapeutics Inc. (NVLN) fell -5.41% or -0.22 to $3.85. It is near 50676 shares traded, which is 51.08% compare to the average total volume 99217. The market cap of NVLN is $71.45 million. The year to date change is 22.22%. The 52 week price range is from $3.08 to $12.12. Price of NVLN have changed 1.24% during last week. It have changed 19.35% over last month, -39.43% over last 3 months, -56.09% over last 6 months and -55.27% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVLN is 3.98. It is 3.38% above current price. The 200-day Moving Averages for NVLN is 7.40. It is 92.21% above current price. The 52-week High is 12.12. It is 214.81% from the current price. The 52-week Low is 3.08. It is -20.00% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NVLN is 16.05 on 2017-12-29. Short % to float is 10.62%. There are some statistics of NVLN. It is has market cap $71.45 million. The share outstanding is 18.56 million. The average volume is 99217. The percent of top 15 Institution holding is 80.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVLN is -216.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVLN is -50.09%.


Tags:

Share this post